Skip to content
10-K

Annual Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000830

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stockholders Equity FY 2021 · Sep 30, 2021 −$326.19K
Stockholders Equity FY 2021 · Sep 30, 2019 −$235.09K
Operating Cash Flow FY 2021 · Sep 30, 2020 −$119
Total Liabilities FY 2021 · Sep 30, 2020 $250.5K
Total Assets FY 2021 · Sep 30, 2020 $408
Net Income FY 2021 · Sep 30, 2020 −$15.01K
Operating Income FY 2021 · Sep 30, 2020 −$5.54K